Insulin Resistance & Metabolic Syndrome

🧠 What Is Insulin Resistance?

Insulin resistance is a physiological condition in which the body’s cells (especially in muscle, fat, and liver) respond less effectively to the hormone insulin. Insulin’s normal role is to help glucose (sugar) enter cells to be used for energy. When cells become resistant, they don’t take up glucose properly, leading to elevated blood glucose levels. The pancreas tries to compensate by secreting more insulin — resulting in hyperinsulinemia.

👉 Insulin resistance is a single metabolic defect — it’s about how cells respond to insulin at the biochemical level (e.g., impaired insulin signalling).

Insulin resistance develops from several interacting factors:

• Obesity, especially central (abdominal) adiposity: Excess visceral fat releases free fatty acids and pro-inflammatory cytokines that interfere with insulin signalling.

• Physical inactivity: Muscles become less efficient at taking up glucose when they’re inactive.

• Genetics: Some people inherit traits that predispose them to poorer insulin sensitivity.

• Chronic inflammation: Fat tissue can produce inflammatory substances that worsen insulin resistance.

• Liver and muscle fat accumulation: Lipid build-up within non-fat tissues further disrupts insulin action.

• Some medications (e.g., certain steroids) and endocrine disorders can also contribute.

Importantly, insulin resistance can exist on its own — even before diabetes or other health problems develop. However, it often progresses over time and is a key early step in metabolic disease.

🧩 What Is Metabolic Syndrome?

Metabolic syndrome is a cluster of risk factors that tend to occur together and increase the risk of cardiovascular disease and type 2 diabetes. Clinical definitions typically require having three or more of the following features:

• High waist circumference (central obesity)

• Elevated fasting blood glucose

• High blood pressure

• Elevated triglycerides

This constellation of abnormalities is associated with insulin resistance, but it’s clinically defined by the presence of multiple metabolic abnormalities, not just impaired insulin action.

Metabolic syndrome is a diagnostic classification used to identify people at high risk of future diabetes and heart disease — it’s not a single biochemical defect, but a syndrome of interrelated conditions.

🔄 How They Relate Pathophysiologically

Insulin resistance is considered to be one of the central mechanisms that contributes to metabolic syndrome, but not the only one. Other factors like adiposity, inflammation, genetics, and lipid abnormalities interact with insulin resistance to produce the full syndrome.

Research indicates that:

• Insulin resistance plays a major role in producing high blood sugar and dyslipidemia.

• Obesity (especially visceral fat) itself contributes to both insulin resistance and other components of the syndrome.

• The syndrome predicts cardiovascular risk beyond any single component.

🧬 Summary

• Insulin resistance is a cellular metabolic problem: cells fail to respond properly to insulin, leading to higher blood glucose and compensatory hyperinsulinemia.

• Metabolic syndrome is a clinical cluster of risk factors that includes insulin resistance but also other abnormalities like high blood pressure and abnormal lipids.

• Insulin resistance is a major cause / driver of metabolic syndrome, but metabolic syndrome reflects broader systemic risk.

🥦 Nutritional Causes of Insulin Resistance

Insulin resistance (IR) — the reduced ability of cells to respond to insulin — is strongly influenced by diet quality and nutrient exposures. Key nutritional contributors include:

🔹 1. High Intake of Refined Carbohydrates & Sugars

• Diets high in refined carbohydrates (white bread, sugary cereals) and added sugars, especially fructose (e.g., sugar-sweetened beverages), increase blood glucose and insulin levels and promote fat deposition in the liver. This dietary pattern is associated with worsened insulin sensitivity and metabolic dysregulation.

  
  

🔹 2. Excess Total Energy / Overnutrition

• Consuming more calories than the body needs — especially from energy-dense, nutrient-poor foods — leads to weight gain and ectopic fat storage (fat in liver and muscle). These changes directly impair insulin signalling.

  
  

🔹 3. Unhealthy Fats

• Diets high in seed oils and trans fats are linked to increased insulin resistance. They may alter cell membrane composition and signalling pathways involved in glucose uptake.

  
  

🔹 4. Imbalanced Fats

• High ratios of omega-6 to omega-3 polyunsaturated fats (common in many processed foods) may promote inflammation and contribute to insulin resistance. Adequate omega-3 intake (e.g., from fish) may have protective effects.

  
  

🍔 Nutritional Causes of Metabolic Syndrome

Because metabolic syndrome (MetS) is a cluster of metabolic abnormalities (obesity, dyslipidaemia, hypertension, high glucose), its nutritional causes overlap with those of insulin resistance but extend into other diet-related risk pathways:

🔹 1. Excess Calories Leading to Central Obesity

• High total energy intake — particularly from ultra-processed and energy-dense foods — leads to abdominal fat accumulation, a central driver of MetS. Visceral adiposity releases free fatty acids and pro-inflammatory compounds that promote insulin resistance, high triglycerides, hypertension, and other risk factors that define MetS.

  
  

🔹 2. High Glycaemic Foods

• Diets rich in high glycaemic index carbohydrates (refined starches and sugars) raise post-meal glucose and insulin sharply, contributing to triglyceride elevation, low HDL cholesterol, and glucose intolerance — all components of MetS.

  
  

🔹 3. Excess Omega-6 Intake & Trans Fats

• Omega-6 fatty acids (linoleic acid) are essential, but very high intakes, especially from ultra-processed foods, is associated with insulin resistance and metabolic syndrome, especially with low omega-3 intake, can promote a pro-inflammatory environment

• Trans fats contribute to dyslipidaemia (elevated triglycerides), a key part of MetS. Conversely, higher intake of monounsaturated fats (e.g., from olive oil) may have protective effects.

  
  

🔹 4. Added Sugars / Sweetened Foods

• Excess sugar intake — especially from sugar-sweetened beverages — contributes to weight gain, fatty liver, inflammation, and metabolic disturbances. These effects promote several components of metabolic syndrome simultaneously.

  
  

🧠 Why Diet Matters at the Physiological Level

🔹 Inflammation & Lipid Overload

• Pro-inflammatory responses triggered by visceral fat and unhealthy diets impair insulin signalling and contribute to the cluster of abnormalities in MetS.

🔹 Liver Fat & Glucose Metabolism

• Excess calories, particularly from sugars, lead to fat deposition in the liver (non-alcoholic fatty liver), worsening both insulin resistance and several metabolic syndrome features.

🔹 Micro- and Macronutrient Balance

• Diets low in antioxidants, magnesium, and other micronutrients are linked to poorer glucose handling and metabolic risk, while diets high in these nutrients are linked to lower metabolic risk.

Alberti, K.G.M.M., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., Fruchart, J.C., James, W.P.T., Loria, C.M. and Smith, S.C. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention, Circulation, 120(16), pp. 1640–1645.

Boden, G. (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM, Diabetes, 46(1), pp. 3–10.

Cornier, M.A., Dabelea, D., Hernandez, T.L., Lindstrom, R.C., Steig, A.J., Stob, N.R., Van Pelt, R.E., Wang, H. and Eckel, R.H. (2008) The metabolic syndrome, Endocrine Reviews, 29(7), pp. 777–822.

Després, J.P. and Lemieux, I. (2006) Abdominal obesity and metabolic syndrome, Nature, 444(7121), pp. 881–887.

Eckel, R.H., Grundy, S.M. and Zimmet, P.Z. (2005) The metabolic syndrome, The Lancet, 365(9468), pp. 1415–1428.

Esposito, K., Kastorini, C.M., Panagiotakos, D.B. and Giugliano, D. (2011) Mediterranean diet and metabolic syndrome: an updated systematic review, Reviews in Endocrine and Metabolic Disorders, 12(3), pp. 195–206.

Fornari Laurindo, L., Rodrigues, D.D., Oliveira, A.L.S.C., Boaro, M.L., Araújo, S.C., Guiguer, R.L., Detregiachi, E.R.P., Catharin, M.C.S. and Barbalho, S.M. (2025) ‘Evaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies’, Journal of Clinical Lipidology, 19(2), pp. 215–230.

Grundy, S.M. (2008) Metabolic syndrome pandemic, Arteriosclerosis, Thrombosis, and Vascular Biology, 28(4), pp. 629–636.

Grundy, S.M., Brewer, H.B., Cleeman, J.I., Smith, S.C. and Lenfant, C. (2004) Definition of metabolic syndrome, Circulation, 109(3), pp. 433–438.

Hotamisligil, G.S. (2006) Inflammation and metabolic disorders, Nature, 444(7121), pp. 860–867.

Hu, F.B., van Dam, R.M. and Liu, S. (2001) Diet and risk of type II diabetes: the role of types of fat and carbohydrate, Diabetologia, 44(7), pp. 805–817.

Jackson, K.H. (2024) ‘Linoleic acid and cardiometabolic health: evidence from biomarkers and clinical trials’, Nutrients, 16(9), 1372. https://doi.org/10.3390/nu16091372

Johnson, R.J., Segal, M.S., Sautin, Y., Nakagawa, T., Feig, D.I., Kang, D.H., Gersch, M.S., Benner, S. and Sánchez-Lozada, L.G. (2007) Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, The American Journal of Clinical Nutrition, 86(4), pp. 899–906.

Kahn, S.E., Hull, R.L. and Utzschneider, K.M. (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes, Nature, 444(7121), pp. 840–846.

Lee, K. and Kurniawan, K. (2025) ‘Are seed oils the culprit in cardiometabolic and chronic diseases?’, Nutrition Reviews, 83(7), pp. e2106–e2112.

López-Moreno, M. (2025) ‘Commentary: the energy model of insulin resistance—a unifying theory linking seed oils to metabolic disease and cancer’, Frontiers in Nutrition, 12, 1622160.

Lusis, A.J., Attie, A.D. and Reue, K. (2008) Metabolic syndrome: from epidemiology to systems biology, Nature Reviews Genetics, 9(11), pp. 819–830.

McLaughlin, T., Allison, G., Abbasi, F., Lamendola, C. and Reaven, G. (2004) Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals, Metabolism, 53(4), pp. 495–499.

Marangoni, F., Agostoni, C., Borghi, C., Catapano, A.L. and Cena, H. (2020) ‘Dietary linoleic acid and human health: focus on cardiovascular and cardiometabolic effects’, The American Journal of Clinical Nutrition, 112(3), pp. 688–698.

Reaven, G.M. (1988) Role of insulin resistance in human disease, Diabetes, 37(12), pp. 1595–1607.

Reaven, G.M. (2005) The insulin resistance syndrome: definition and dietary approaches to treatment, Annual Review of Nutrition, 25, pp. 391–406.

Sacks, F.M., Lichtenstein, A.H., Wu, J.H.Y., Appel, L.J., Creager, M.A., Kris-Etherton, P.M., Miller, M., Rimm, E.B., Rudel, L.L., Robinson, J.G., Stone, N.J. and Van Horn, L.V. (2017) ‘Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association’, Circulation, 136(3), pp. e1–e23.

Swinburn, B.A., Caterson, I., Seidell, J.C. and James, W.P.T. (2004) Diet, nutrition and the prevention of excess weight gain and obesity, Public Health Nutrition, 7(1a), pp. 123–146.

Tchernof, A. and Després, J.P. (2013) Pathophysiology of human visceral obesity, Physiological Reviews, 93(1), pp. 359–404.

Uusitupa, M., Hermansen, K., Savolainen, M.J., Schwab, U., Kolehmainen, M., Brader, L., Mortensen, L.S. and Cloetens, L. (2013) Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers, Diabetes Care, 36(9), pp. 2566–2573.

Yamashima, T. (2020) ‘Dietary intake of ω-6 polyunsaturated fatty acid-rich vegetable oils and their oxidative metabolites in lifestyle-related diseases’, Journal of Nutritional Science, 9, e14.

Zong, G., Li, Y., Wanders, A.J., Alssema, M., Zock, P.L., Willett, W.C., Hu, F.B. and Sun, Q. (2016) ‘Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies’, BMJ, 355, i5796.